MYC and osteosarcoma: Transcriptomic profiling of osteoblastic osteosarcoma cells demonstrated a higher activation of oxidative phosphorylation, reactive oxygen species, mTORC1, hypoxia signaling pathways, and MYC gene targets in lung metastases than primary and recurrent tissues.